Cargando…
Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252385/ http://dx.doi.org/10.1016/S0168-8278(22)00986-2 |
_version_ | 1784740252595781632 |
---|---|
author | Jorgensen, Kristin Chopra, Adity Sexton, Joseph Tveter, Anne T Hov, Johannes R. Jyssum, Ingrid Nissen-Meyer, Lise Sofie H. Vaage, John T Syversen, Silje W Goll, Guro L Lund-Johansen, Fridtjof Jahnsen, Jørgen |
author_facet | Jorgensen, Kristin Chopra, Adity Sexton, Joseph Tveter, Anne T Hov, Johannes R. Jyssum, Ingrid Nissen-Meyer, Lise Sofie H. Vaage, John T Syversen, Silje W Goll, Guro L Lund-Johansen, Fridtjof Jahnsen, Jørgen |
author_sort | Jorgensen, Kristin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9252385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Association for the Study of the Liver. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92523852022-07-05 Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study Jorgensen, Kristin Chopra, Adity Sexton, Joseph Tveter, Anne T Hov, Johannes R. Jyssum, Ingrid Nissen-Meyer, Lise Sofie H. Vaage, John T Syversen, Silje W Goll, Guro L Lund-Johansen, Fridtjof Jahnsen, Jørgen J Hepatol POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252385/ http://dx.doi.org/10.1016/S0168-8278(22)00986-2 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects Jorgensen, Kristin Chopra, Adity Sexton, Joseph Tveter, Anne T Hov, Johannes R. Jyssum, Ingrid Nissen-Meyer, Lise Sofie H. Vaage, John T Syversen, Silje W Goll, Guro L Lund-Johansen, Fridtjof Jahnsen, Jørgen Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
title | Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
title_full | Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
title_fullStr | Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
title_full_unstemmed | Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
title_short | Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
title_sort | immune response and safety in standard and third dose sars-cov-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study |
topic | POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252385/ http://dx.doi.org/10.1016/S0168-8278(22)00986-2 |
work_keys_str_mv | AT jorgensenkristin immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT chopraadity immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT sextonjoseph immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT tveterannet immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT hovjohannesr immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT jyssumingrid immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT nissenmeyerlisesofieh immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT vaagejohnt immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT syversensiljew immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT gollgurol immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT lundjohansenfridtjof immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy AT jahnsenjørgen immuneresponseandsafetyinstandardandthirddosesarscov2vaccinationinpatientswithautoimmunehepatitisonimmunosupressivetherapyaprospectivecohortstudy |